<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC7507145</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC7507145.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">7507145</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">7507145</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">32383552</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1111/gbb.12656</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">GBB12656</article-id></all-ids><extracted-table><table-id>gbb12656-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>SNPs that were used to build the GRSs.</table-caption><table-wrap-foot>Note: 15 SNPs could be assigned to at least one of the pathways identified as showing enrichment for association with late‐onset AD. The pathway protein ubiquitination was excluded because none of the SNPS could assigned to this pathway. Notice that only immune/inflammatory response and endocytosis are completely independent pathways. Abbreviations: Immune resp., immune response; Cholesterol/lipid met., cholesterol/lipid metabolism; Synaptic trans., synaptic transmission; 1, OR extracted from reference 18; 2, OR extracted from reference 19; *, belongs to.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="gbb12656-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>SNPs that were used to build the GRSs.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">SNP</th><th align="left" valign="bottom" rowspan="1" colspan="1">Gene</th><th align="left" valign="bottom" rowspan="1" colspan="1">Odds‐ratio</th><th align="left" valign="bottom" rowspan="1" colspan="1">Immune response</th><th align="left" valign="bottom" rowspan="1" colspan="1">Endocytosis</th><th align="left" valign="bottom" rowspan="1" colspan="1">Cholesterol/lipid metabolism</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">rs4147929</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">ABCA7</italic></td><td align="char" valign="top" rowspan="1" colspan="1">1.15<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs7412</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">APOE2</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.67<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs429358</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">APOE4</italic></td><td align="char" valign="top" rowspan="1" colspan="1">3.86<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs6733839</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">BIN1</italic></td><td align="char" valign="top" rowspan="1" colspan="1">1.22<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs10948363</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">CD2AP</italic></td><td align="char" valign="top" rowspan="1" colspan="1">1.10<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs9331896</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">CLU</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.86<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs6656401</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">CR1</italic></td><td align="char" valign="top" rowspan="1" colspan="1">1.18<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs11771145</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">EPHA1</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.90<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs35349669</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">INPP5D</italic></td><td align="char" valign="top" rowspan="1" colspan="1">1.08<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs190982</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">MEF2C</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.93<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs983392</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">MS4A64</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.90<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs10792832</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">PICALM</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.87<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs28834970</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">PTK2B</italic></td><td align="char" valign="top" rowspan="1" colspan="1">1.10<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs11218343</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">SORL1</italic></td><td align="char" valign="top" rowspan="1" colspan="1">0.77<sup>1</sup></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1">*</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">rs75932628</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">TREM2</italic></td><td align="char" valign="top" rowspan="1" colspan="1">2.43<sup>2</sup></td><td align="left" valign="top" rowspan="1" colspan="1">*</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot id="gbb12656-ntgp-1001"><fn id="gbb12656-note-1001"><p><italic toggle="yes">Note</italic>: 15 SNPs could be assigned to at least one of the pathways identified as showing enrichment for association with late‐onset AD. The pathway protein ubiquitination was excluded because none of the SNPS could assigned to this pathway. Notice that only immune/inflammatory response and endocytosis are completely independent pathways. Abbreviations: Immune resp., immune response; Cholesterol/lipid met., cholesterol/lipid metabolism; Synaptic trans., synaptic transmission; 1, OR extracted from reference 18; 2, OR extracted from reference 19; *, belongs to.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">SNPs that were used to build the GRSs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">SNP</th><th align="left" valign="bottom">Gene</th><th align="left" valign="bottom">Odds‐ratio</th><th align="left" valign="bottom">Immune response</th><th align="left" valign="bottom">Endocytosis</th><th align="left" valign="bottom">Cholesterol/lipid metabolism</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">rs4147929</td><td align="left" valign="top">ABCA7</td><td align="char" valign="top">1.151</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">*</td></tr><tr><td align="left" valign="top">rs7412</td><td align="left" valign="top">APOE2</td><td align="char" valign="top">0.671</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">*</td></tr><tr><td align="left" valign="top">rs429358</td><td align="left" valign="top">APOE4</td><td align="char" valign="top">3.861</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">*</td></tr><tr><td align="left" valign="top">rs6733839</td><td align="left" valign="top">BIN1</td><td align="char" valign="top">1.221</td><td align="left" valign="top"/><td align="left" valign="top">*</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs10948363</td><td align="left" valign="top">CD2AP</td><td align="char" valign="top">1.101</td><td align="left" valign="top"/><td align="left" valign="top">*</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs9331896</td><td align="left" valign="top">CLU</td><td align="char" valign="top">0.861</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top">*</td></tr><tr><td align="left" valign="top">rs6656401</td><td align="left" valign="top">CR1</td><td align="char" valign="top">1.181</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs11771145</td><td align="left" valign="top">EPHA1</td><td align="char" valign="top">0.901</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs35349669</td><td align="left" valign="top">INPP5D</td><td align="char" valign="top">1.081</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs190982</td><td align="left" valign="top">MEF2C</td><td align="char" valign="top">0.931</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs983392</td><td align="left" valign="top">MS4A64</td><td align="char" valign="top">0.901</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs10792832</td><td align="left" valign="top">PICALM</td><td align="char" valign="top">0.871</td><td align="left" valign="top"/><td align="left" valign="top">*</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs28834970</td><td align="left" valign="top">PTK2B</td><td align="char" valign="top">1.101</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">rs11218343</td><td align="left" valign="top">SORL1</td><td align="char" valign="top">0.771</td><td align="left" valign="top"/><td align="left" valign="top">*</td><td align="left" valign="top">*</td></tr><tr><td align="left" valign="top">rs75932628</td><td align="left" valign="top">TREM2</td><td align="char" valign="top">2.432</td><td align="left" valign="top">*</td><td align="left" valign="top"/><td align="left" valign="top"/></tr></tbody></table></div>Note: 15 SNPs could be assigned to at least one of the pathways identified as showing enrichment for association with late‐onset AD. The pathway protein ubiquitination was excluded because none of the SNPS could assigned to this pathway. Notice that only immune/inflammatory response and endocytosis are completely independent pathways. Abbreviations: Immune resp., immune response; Cholesterol/lipid met., cholesterol/lipid metabolism; Synaptic trans., synaptic transmission; 1, OR extracted from reference 18; 2, OR extracted from reference 19; *, belongs to.</transformed-table></extracted-table><extracted-table><table-id>gbb12656-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Summary of k‐means cluster analysis.</table-caption><table-wrap-foot>Abbreviations: CI, confidence interval; FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation; SE, standard error.Note: Both models were adjusted by age, gender and four principal components of ancestry. Coefficients were calculated using z‐values therefore β represents change in terms of SD from the mean.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="gbb12656-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 2</label><caption><p>Summary of k‐means cluster analysis.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">GRS</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">β</italic></th><th align="left" valign="bottom" rowspan="1" colspan="1">SE</th><th align="left" valign="bottom" rowspan="1" colspan="1">CI lower</th><th align="left" valign="bottom" rowspan="1" colspan="1">CI upper</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">P</italic>‐value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">IQ</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Immune response</td><td align="char" valign="top" rowspan="1" colspan="1">−.259</td><td align="char" valign="top" rowspan="1" colspan="1">.123</td><td align="char" valign="top" rowspan="1" colspan="1">−.500</td><td align="char" valign="top" rowspan="1" colspan="1">−.017</td><td align="char" valign="top" rowspan="1" colspan="1">.036</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Endocytosis</td><td align="char" valign="top" rowspan="1" colspan="1">−.015</td><td align="char" valign="top" rowspan="1" colspan="1">.116</td><td align="char" valign="top" rowspan="1" colspan="1">−.243</td><td align="char" valign="top" rowspan="1" colspan="1"> .212</td><td align="char" valign="top" rowspan="1" colspan="1">.895</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cholesterol/lipid metabolism</td><td align="char" valign="top" rowspan="1" colspan="1"> .030</td><td align="char" valign="top" rowspan="1" colspan="1">.031</td><td align="char" valign="top" rowspan="1" colspan="1">−.031</td><td align="char" valign="top" rowspan="1" colspan="1"> .092</td><td align="char" valign="top" rowspan="1" colspan="1">.335</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FA</td><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Immune response</td><td align="char" valign="top" rowspan="1" colspan="1">−.373</td><td align="char" valign="top" rowspan="1" colspan="1">.177</td><td align="char" valign="top" rowspan="1" colspan="1">−.721</td><td align="char" valign="top" rowspan="1" colspan="1">−.026</td><td align="char" valign="top" rowspan="1" colspan="1">.035</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Endocytosis</td><td align="char" valign="top" rowspan="1" colspan="1"> .122</td><td align="char" valign="top" rowspan="1" colspan="1">.167</td><td align="char" valign="top" rowspan="1" colspan="1">−.205</td><td align="char" valign="top" rowspan="1" colspan="1"> .449</td><td align="char" valign="top" rowspan="1" colspan="1">.465</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cholesterol/lipid metabolism</td><td align="char" valign="top" rowspan="1" colspan="1">−.077</td><td align="char" valign="top" rowspan="1" colspan="1">.046</td><td align="char" valign="top" rowspan="1" colspan="1">−.167</td><td align="char" valign="top" rowspan="1" colspan="1"> .013</td><td align="char" valign="top" rowspan="1" colspan="1">.094</td></tr></tbody></table><table-wrap-foot id="gbb12656-ntgp-0001"><fn id="gbb12656-note-0001"><p>Abbreviations: CI, confidence interval; FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation; SE, standard error.</p></fn><fn id="gbb12656-note-1501"><p><italic toggle="yes">Note</italic>: Both models were adjusted by age, gender and four principal components of ancestry. Coefficients were calculated using z‐values therefore β represents change in terms of SD from the mean.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of k‐means cluster analysis.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">GRS</th><th align="left" valign="bottom">β</th><th align="left" valign="bottom">SE</th><th align="left" valign="bottom">CI lower</th><th align="left" valign="bottom">CI upper</th><th align="left" valign="bottom">P‐value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">IQ</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td style="padding-left:10%" align="left" valign="top">Immune response</td><td align="char" valign="top">−.259</td><td align="char" valign="top">.123</td><td align="char" valign="top">−.500</td><td align="char" valign="top">−.017</td><td align="char" valign="top">.036</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Endocytosis</td><td align="char" valign="top">−.015</td><td align="char" valign="top">.116</td><td align="char" valign="top">−.243</td><td align="char" valign="top"> .212</td><td align="char" valign="top">.895</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Cholesterol/lipid metabolism</td><td align="char" valign="top"> .030</td><td align="char" valign="top">.031</td><td align="char" valign="top">−.031</td><td align="char" valign="top"> .092</td><td align="char" valign="top">.335</td></tr><tr><td align="left" valign="top">FA</td><td align="char" valign="top"/><td align="char" valign="top"/><td align="char" valign="top"/><td align="char" valign="top"/><td align="char" valign="top"/></tr><tr><td style="padding-left:10%" align="left" valign="top">Immune response</td><td align="char" valign="top">−.373</td><td align="char" valign="top">.177</td><td align="char" valign="top">−.721</td><td align="char" valign="top">−.026</td><td align="char" valign="top">.035</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Endocytosis</td><td align="char" valign="top"> .122</td><td align="char" valign="top">.167</td><td align="char" valign="top">−.205</td><td align="char" valign="top"> .449</td><td align="char" valign="top">.465</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Cholesterol/lipid metabolism</td><td align="char" valign="top">−.077</td><td align="char" valign="top">.046</td><td align="char" valign="top">−.167</td><td align="char" valign="top"> .013</td><td align="char" valign="top">.094</td></tr></tbody></table></div>Abbreviations: CI, confidence interval; FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation; SE, standard error.Note: Both models were adjusted by age, gender and four principal components of ancestry. Coefficients were calculated using z‐values therefore β represents change in terms of SD from the mean.</transformed-table></extracted-table><extracted-table><table-id>gbb12656-tbl-0003</table-id><table-label>TABLE 3</table-label><table-caption>Summary of k‐means cluster analysis. </table-caption><table-wrap-foot>Abbreviations: FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation.Note: Analysis included children with moderate to severe intellectual disability (IQ lower than 70). Values for IQ, global FA and immune response GRS are showed for the two clusters that were computed.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="gbb12656-tbl-0003" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 3</label><caption><p>Summary of k‐means cluster analysis. </p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Cluster 1</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Cluster 2</th><th rowspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Statistics</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">Mean</th><th align="left" valign="bottom" rowspan="1" colspan="1">SD</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mean</th><th align="left" valign="bottom" rowspan="1" colspan="1">SD</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">IQ</td><td align="char" valign="top" rowspan="1" colspan="1">111.850</td><td align="char" valign="top" rowspan="1" colspan="1">13.132</td><td align="char" valign="top" rowspan="1" colspan="1">101.748</td><td align="char" valign="top" rowspan="1" colspan="1">14.161</td><td align="char" valign="top" rowspan="1" colspan="1"><italic toggle="yes">t</italic> = 11.39, df = 2, <italic toggle="yes">P</italic> &lt; .001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Global FA</td><td align="char" valign="top" rowspan="1" colspan="1">1.140</td><td align="char" valign="top" rowspan="1" colspan="1">1.390</td><td align="char" valign="top" rowspan="1" colspan="1">−.991</td><td align="char" valign="top" rowspan="1" colspan="1">1.473</td><td align="char" valign="top" rowspan="1" colspan="1"><italic toggle="yes">t</italic> = 22.91, df = 2, <italic toggle="yes">P</italic> &lt; .001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Immune response GRS</td><td align="char" valign="top" rowspan="1" colspan="1">−.154</td><td align="char" valign="top" rowspan="1" colspan="1">.157</td><td align="char" valign="top" rowspan="1" colspan="1">.032</td><td align="char" valign="top" rowspan="1" colspan="1">.166</td><td align="char" valign="top" rowspan="1" colspan="1"><italic toggle="yes">t</italic> = −17.74, df = 2, <italic toggle="yes">P</italic> &lt; .001</td></tr></tbody></table><table-wrap-foot id="gbb12656-ntgp-0002"><fn id="gbb12656-note-0002"><p>Abbreviations: FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation.</p></fn><fn id="gbb12656-note-0151"><p><italic toggle="yes">Note</italic>: Analysis included children with moderate to severe intellectual disability (IQ lower than 70). Values for IQ, global FA and immune response GRS are showed for the two clusters that were computed.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of k‐means cluster analysis. </div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th style="border-bottom:solid 1px #000000" align="left" valign="bottom"/><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom">Cluster 1</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom">Cluster 2</th><th rowspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom">Statistics</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom"/><th align="left" valign="bottom">Mean</th><th align="left" valign="bottom">SD</th><th align="left" valign="bottom">Mean</th><th align="left" valign="bottom">SD</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">IQ</td><td align="char" valign="top">111.850</td><td align="char" valign="top">13.132</td><td align="char" valign="top">101.748</td><td align="char" valign="top">14.161</td><td align="char" valign="top">t = 11.39, df = 2, P &lt; .001</td></tr><tr><td align="left" valign="top">Global FA</td><td align="char" valign="top">1.140</td><td align="char" valign="top">1.390</td><td align="char" valign="top">−.991</td><td align="char" valign="top">1.473</td><td align="char" valign="top">t = 22.91, df = 2, P &lt; .001</td></tr><tr><td align="left" valign="top">Immune response GRS</td><td align="char" valign="top">−.154</td><td align="char" valign="top">.157</td><td align="char" valign="top">.032</td><td align="char" valign="top">.166</td><td align="char" valign="top">t = −17.74, df = 2, P &lt; .001</td></tr></tbody></table></div>Abbreviations: FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard deviation.Note: Analysis included children with moderate to severe intellectual disability (IQ lower than 70). Values for IQ, global FA and immune response GRS are showed for the two clusters that were computed.</transformed-table></extracted-table></extracted-tables-set>